Lianyungang, China

Haomin Chen

This inventor holds 1 USPTO granted patent. Top assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Medshine Discovery Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haomin Chen. Retrieved from https://idiyas.com/inventor/haomin-chen-krxpwrbx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haomin Chen - Innovator in Bicyclic Compounds

Introduction

Haomin Chen is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on bicyclic compounds.

Latest Patents

Haomin Chen holds a patent for a bicyclic compound acting as a RORγ inhibitor. This compound, represented by formula (I) or a pharmaceutically acceptable salt thereof, demonstrates good RORγ inhibitory activities. It is expected to be utilized in treating diseases mediated by RORγ receptors in mammals.

Career Highlights

Throughout his career, Haomin Chen has worked with prominent companies in the pharmaceutical industry. Notable among these are Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Medshine Discovery Inc. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Haomin Chen has collaborated with several professionals in his field, including Kevin X Chen and Kai Zhou. These partnerships have fostered innovation and enhanced research outcomes in the pharmaceutical sector.

Conclusion

Haomin Chen's contributions to the field of bicyclic compounds and his collaborations with industry professionals highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…